Healio Rheumatology Current Issue

The following articles appeared in the print edition of Healio Rheumatology.

Table of Contents

• ‘The writing is on the wall’: The ever expanding, evolving role of APPs in rheumatology Rob Volansky
• Notes from the field: My personal journey of collaborative practice with APPs Leonard H. Calabrese, DO
• ACR integrative guidelines for RA make sense of ‘messy’ data on diet, wellness Rob Volansky
• Algorithm scans outpatient letters, identifies those who must ‘shield’ against COVID-19 Justin Cooper
• Amjevita leads Humira biosimilars in clinician comfort as rheumatologists remain wary Rob Volansky
• Attention, inhibitory control lower in patients with lupus vs. general population Justin Cooper
• Blood test predicts knee osteoarthritis up to 8 years in advance Justin Cooper
• Changes in infusion drug insurance coverage jeopardize ‘hard-won’ disease control Rob Volansky
• Deucravacitinib improves ‘broad range’ of patient-reported psoriatic arthritis outcomes Justin Cooper
• Difficult-to-treat psoriatic arthritis ‘not all about the therapies’ Justin Cooper
• ‘Exciting time’: Biologic use in moderate to severe lupus rose 45% since 2021 Rob Volansky
• Exercise in lupus should be individually tailored, professionally supervised Justin Cooper
• FDA approves Selarsdi as Stelara biosimilar for psoriasis, psoriatic arthritis
• FDA approves updated label for Lupkynis with long-term data, new monitoring guidelines
• FDA grants orphan drug designation for potential scleroderma treatment
• Federal Trade Commission bans most noncompete agreements Stephanie C. Viguers
• ‘Full cancer screening’ essential for patients of all ages with dermatomyositis Rob Volansky
• Henoch-Schönlein purpura incidence fell, rose with COVID-19 protective measures Justin Cooper
• Nearly 70% of VA rheumatology chiefs want more point-of-care ultrasound training Justin Cooper
• Nearly 75% of patients with systemic sclerosis need specialist palliative care Justin Cooper
• New EULAR recommendations for psoriatic arthritis urge biologics after methotrexate failure Justin Cooper
• Patients with long COVID ‘should not be discouraged from exercising,’ study suggests Andrew (Drew) Rhoades
• Proposed biosimilar shows equivalence to golimumab in rheumatoid arthritis
• Purpose of urate-lowering therapy ‘needs to be reinforced every time patients come in’ Justin Cooper
• SNOT-22 questionnaire predicts ANCA-associated vasculitis relapse risk up to 2 years Justin Cooper
• VIDEO: Medicare reimbursement reform critical to ‘keep our doors open’ to senior patients Robert Stott
• ‘We are all busy’: Journal clubs offer data, connection for rheumatology experts, trainees Rob Volansky